Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Autoinjectors are special devices used in medicine to give a dose of a drug. Most of them work like a syringe with a spring. The global market for these autoinjectors is growing because more and more people are getting older, and there is a higher demand for these devices worldwide. People are also becoming more aware of different diseases that need special treatments. But, there are strict rules and regulations that companies must follow, and sometimes, these rules can slow down the growth of the market.
From 2019 to 2024, the global market for autoinjectors is expected to grow at a rate of 17.42%. In 2018, the Americas led the market with 40.6%, followed by Europe at 30.1%, and Asia-Pacific at 22.4%.
The autoinjectors market is divided into different parts based on the type of product, how it's designed, what it's used for, where it's sold, and where in the world it's used.
When we look at the type of product, disposable autoinjectors make up the biggest part, with a share of 65.7% in 2018, worth USD 20,222.59 million. This part of the market is expected to keep growing at a rate of 17.90%. The design of these autoinjectors is important too. Customized autoinjectors have the largest share at 55.0% in 2018, worth USD 16,931.25 million. This part of the market is projected to grow at a rate of 18.13%. For what the autoinjectors are used for, the biggest part is for treating anaphylaxis, with a share of 35.0% in 2018, worth USD 10,763.20 million. This part of the market is expected to grow at a rate of 17.80%. Finally, when we look at where these autoinjectors are sold, retail pharmacies make up the largest part, with a share of 55.7% in 2018, worth USD 17,150.37 million. This part of the market is expected to grow at a rate of 17.74%.
In simple terms, more people needing medicine and growing awareness about different diseases are making the market for autoinjectors bigger. But, there are rules that companies must follow, which can sometimes slow down the growth. The disposable autoinjectors, customized designs, and those used for treating anaphylaxis are the biggest parts of the market. Retail pharmacies are the main places where these devices are sold. The market is expected to keep growing over the next few years.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Market Size Value In 2023 | USD 1.3002 Billion |
| Growth Rate | 18.20% (2023-2030) |
Autoinjectors Market Highlights:
Global Auto injector Market Overview
Autoinjectors Market: Valued at USD 1.2 billion in 2023, projected to grow from USD 1.3 billion in 2024 to USD 2.72 billion by 2032, exhibiting a CAGR of 12.40% during the forecast period (2024 - 2032). The rising frequency of widespread use of epinephrine injectors, adrenaline, and food allergens & anaphylaxis are the market drivers enhancing market growth.
Auto injector Market Trends
- Rising awareness among patients boost market growth
The key factors driving the growth of auto injectors are increasing awareness among patients, as auto injectors are self-administrative, an increase in anaphylactic shocks, and others. As auto injectors are the least expensive home medicine solution, the market is also expanding. It reduces the need for medical professionals, which accelerates response times.
The aging population and high demand and biologics production adversely affect the growth of auto injectors. Research and development firms are trying to create new, affordable treatments for chronic diseases like multiple sclerosis and rheumatoid arthritis. It will likely increase the market's value in the coming years and reach incredibly high levels.
Restraints
It is estimated that the market's CAGR will increase to a maximum of 23.3% during the forecast period. Yet, several difficulties at this early stage could constitute barriers and limit the market growth for auto injectors. The fact that several alternatives can impede the market expansion for auto injectors is yet another factor that makes it difficult. Although they can be substituted with oral tablets, injections, and other methods, auto injectors are expensive, and their availability may be limited. Notwithstanding these limitations, the industry will experience strong growth during the forecasted period.
After COVID-19, the auto injectors market has a lot of new opportunities. Restricted markets everywhere, except health industries, helped the industry to survive. New initiatives and substantial investment in the healthcare sector are most likely to accelerate. Auto injector Maket revenue.
Auto injector Market Segment Insights
Auto injector by Product Insights
The Auto injector market segmentation can be classified into several categories based on product the auto injector market include Disposable, Reusable. The disposable segment is expected to dominate the market over the forecast period such as disposable auto injectors and reusable auto injectors. There are several types of auto injectors on the market, with disposable auto injectors holding the most significant market revenue because of their built-in glass syringes, ease of use, and patient friendliness.
Experience and Eversana have formed a cooperation for 2021 that aims to optimize manufacturing, development, commercialization, and meal planning.
A contract was struck in August 2020 between the US-based Antares Pharma and the Dubai-based Lunatus Medical Supply. The transaction was made possible by XYOSTED's supply and Saudi Arabia's regulatory approvals.
Auto injectors made without plastic and with zero carbon emissions will soon experience significant market growth.
Figure 1 Auto injector Market, by Product Type, 2023 & 2032 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Auto injectors By Therapeutic Application Insights
The Auto injector market segmentation, based on By Therapeutic Application, The therapeutic sub-segment includes Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Others. Rheumatoid arthritis is the most prevalent among them due to the size of its patient base. Rheumatoid arthritis affects more than 43.7 million persons in the United States annually. That raises market growth.
Auto injectors By Distribution Channel Insights
The end-user market data based on distribution channel, includes Retail Pharmacies, Hospital Pharmacies and Others. Hospitals held the majority share in 2022 concerning the Auto injector market revenue, followed by home health and other settings. Since chronic diseases are becoming more common and technology is advancing, home care settings dominate the market.
In March 2020, SHL Medical (Switzerland) bought Weibel CDS. This acquisition improved SHL Medical's capacity to offer more sophisticated drug delivery systems with features that put people first and broadened the growth opportunity for the Auto injector industry.
A disposable auto injector called the BD Intevia 1ml Disposable Auto injector was introduced by Becton, Dickinson, and Company (US) in November 2019.
Auto injector Regional Insights
By Region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Auto injector Market accounted for USD 1.3 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period. This is attributed to the growing incidence like chronic diseases, autoimmune conditions, and anaphylaxis has become more prevalent across the region.
Further, the major countries studiedin the market reportare The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3 AUTO INJECTOR MARKET SHARE BY REGION 2022 (%)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Auto injector Market will reach Twenty-eight million people by 2027. This market is expanding due to several factors, including the development of innovative medication delivery systems, enhanced healthcare infrastructure, and technological advancements. Because chronic diseases are common in most of these areas, the market is expanding and earning more money. Further, the Germany Auto injector Market held the largest market share, and the UK Auto injector Market was the fastest growing market in the European region
The Asia Pacific Auto injector Market region, after America, holds a majority market share. In addition, the Indian Auto injector market is expected to grow at approximately 18.90% during the forecast period.
The Asia-Pacific Auto injector Market is expected to grow at the fastest CAGR from 2024 to 2032. The key players are fastest increasing their presence in the Asia Pacific Auto injector market, including opening sales offices and forming partnerships with local pharmaceutical companies. Further, the China Auto injector Market held the largest market share, and the India Auto injector Market was the fastest growing market in the region
Auto injector Key Market Players& Competitive Insights
Major market players are spending a lot of money on R&D to increase their product lines, which will help the Auto injector Maket grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the auto injector industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
One of the primary business strategies adopted by manufacturers in the Auto injectorindustry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, auto injector industry has provided most significant benefits. The Auto injector Market major player like Abbvie, Amgen, AstraZeneca, Bayer, Becton, Dickinson and Company, Biogen, Eli Lilly, Novartis, Teva Pharmaceuticals, and Ypsomed, among others, hold a substantial market share in the Auto-Injectors market.
SHL Medical, a Swiss manufacturer of cutting-edge delivery tools such as wearable medication delivery systems, auto injectors, pen injectors, and sophisticated inhalers, bought Weibel CDS in March 2020 for an unknown sum. SHL anticipates growing its selection of cutting-edge injection device drug delivery systems due to this acquisition. The research and development of patch injection systems and devices is the area of expertise for the Swiss medical technology company Weibel CDS.
The Qfinity auto injector platform, a straightforward, reusable, and cost-effective solution for subcutaneous (SC) drug self-administration, was introduced by Jabil Healthcare, a branch of Jabil Inc., in May 2022.
Stevanato Group S.p.A. inked an exclusive contract for its Aidaptus auto injector in May 2022 with Owen Mumford Ltd., one of the top producers and innovators of medical devices.
Key Companies in the Auto injector Market includes
Auto injector Industry Developments
Experience and Eversana have formed a cooperation for 2021 that aims to optimize manufacturing, development, commercialization, and meal planning.
A contract was struck in August 2020 between the US-based Antares Pharma and the Dubai-based Lunatus Medical Supply. The transaction was made possible by XYOSTED's supply and Saudi Arabia's regulatory approvals.
Auto injectors made without plastic and with zero carbon emissions will soon experience significant market growth.
In March 2020, SHL Medical (Switzerland) bought Weibel CDS. This acquisition improved SHL Medical's capacity to offer more sophisticated drug delivery systems with features that put people first and broadened the growth opportunity for the Auto injector industry.
Auto injector Market Segmentation
Auto injector By Product Type Outlook
- Disposable
- Reusable
Auto injector by Therapeutic Application Outlook
- Anaphylaxis
- Rheumatoid Arthritis
- Multiple Sclerosis
- Diabetes
- Others
Auto injector Distribution Channel Outlook
- Retail Pharmacies
- Hospital Pharmacies
- Others
Auto injector Regional Outlook
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
